UBS Group’s Bluejay Diagnostics BJDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $764 | Sell |
444
-368
| -45% | -$633 | ﹤0.01% | 8418 |
|
|
2025
Q1 | $3.03K | Sell |
812
-1,133
| -58% | -$4.23K | ﹤0.01% | 7940 |
|
|
2024
Q4 | $9.47K | Sell |
1,945
-59,503
| -97% | -$290K | ﹤0.01% | 7118 |
|
|
2024
Q3 | $7.8K | Buy |
+61,448
| New | +$7.8K | ﹤0.01% | 6663 |
|
|
2023
Q3 | – | Sell |
-5,158
| Closed | -$1.36K | – | 8296 |
|
|
2023
Q2 | $1.36K | Buy |
+5,158
| New | +$1.36K | ﹤0.01% | 6855 |
|
|
2023
Q1 | – | Sell |
-10,061
| Closed | -$3.82K | – | 8487 |
|
|
2022
Q4 | $3.82K | Sell |
10,061
-3,364
| -25% | -$1.28K | ﹤0.01% | 8247 |
|
|
2022
Q3 | $10K | Buy |
13,425
+13,174
| +5,249% | +$9.81K | ﹤0.01% | 7301 |
|
|
2022
Q2 | $0 | Sell |
251
-5,340
| -96% | – | ﹤0.01% | 9250 |
|
|
2022
Q1 | $6K | Buy |
5,591
+577
| +12% | +$619 | ﹤0.01% | 7894 |
|
|
2021
Q4 | $13K | Buy |
+5,014
| New | +$13K | ﹤0.01% | 7310 |
|